The efficacy of integrated cognitive behavioral therapy (CBT) and acupressure versus CBT for insomnia: a three-arm pilot randomized controlled trial

被引:8
作者
Ho, Fiona Yan-Yee [1 ]
Choi, Wing-Ting [2 ]
Yeung, Wing-Fai [3 ]
Lam, Hiu-Kwan [1 ]
Lau, Wing-Yin [1 ]
Chung, Ka-Fai [4 ]
机构
[1] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China
[2] Pamela Youde Nethersole Eastern Hosp, Dept Clin Psychol, Chai Wan, Hong Kong, Peoples R China
[3] Hong Kong Polytech Univ, Sch Nursing, Hunghom, Hong Kong, Peoples R China
[4] Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China
关键词
Cognitive behavioral therapy; Acupressure; Randomized controlled trial; Insomnia; MULTIDIMENSIONAL FATIGUE INVENTORY; SELF-ADMINISTERED ACUPRESSURE; SYMPTOM MANAGEMENT; HOSPITAL ANXIETY; SLEEP QUALITY; CHINESE; VALIDATION; PAIN; COMPLEMENTARY; METAANALYSIS;
D O I
10.1016/j.sleep.2021.08.024
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: This pilot study aimed to examine the efficacy of integrated cognitive behavioral therapy (CBT) and acupressure in treating insomnia and its daytime impairments in a Chinese adult population. Methods: 40 eligible participants with insomnia were randomly assigned to either the integrated CBT and acupressure (CBTAcup) group (n = 14), the CBT group (n = 13), or the waitlist control (WL) group (n = 13). Participants in the CBTAcup group attended a 2-hour integrated CBT and self-administered acupressure group treatment once per week for six consecutive weeks, while participants in the CBT group attended six weekly 2-hour CBT for insomnia. Sleep, mood, daytime impairments, quality of life, and treatment credibility and adherence were assessed at baseline, immediate post-treatment (Week 7), and 4-week post-treatment (Week 11). Results: Linear mixed-effects models showed that both the CBTAcup and CBT groups had significantly lower insomnia severity (d =-1.74 and d =-2.61), dysfunctional beliefs related to sleep (d =-2.17 and-2.76), and mental fatigue (d =-1.43 and-1.60) compared with the WL group at Week 7. The CBTAcup group provided additional benefits in reducing total fatigue (d =-1.43) and physical fatigue (d =-1.45). Treatment credibility was found to be improved in the CBTAcup group from baseline to Week 7. Conclusions: Integrated CBT and acupressure demonstrated comparable efficacy to pure CBT in treating insomnia symptoms, with additional advantages to improve fatigue symptoms and acceptability in the Chinese population. Further methodologically rigorous studies on a larger scale and longer follow-up are warranted to confirm these findings. (c) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 48 条
[1]  
Abedian Z, 2015, IRAN J MED SCI, V40, P328
[2]  
[Anonymous], 2005, SLEEP, V28, P1049
[3]  
[Anonymous], 2003, Insomnia: A clinical guide to assessment and treatment
[4]   The effectiveness of behavioural and cognitive behavioural therapies for insomnia on depressive and fatigue symptoms: A systematic review and network meta-analysis [J].
Ballesio, Andrea ;
Aquino, Maria Raisa Jessica V. ;
Feige, Bernd ;
Johann, Anna F. ;
Kyle, Simon D. ;
Spiegelhalder, Kai ;
Lombardo, Caterina ;
Rucker, Gerta ;
Riemann, Dieter ;
Baglioni, Chiara .
SLEEP MEDICINE REVIEWS, 2018, 37 :114-129
[5]   The Integration of Complementary and Alternative Medicine (CAM) Into the Practice of Psychology: A Vision for the Future [J].
Barnett, Jeffrey E. ;
Shale, Allison J. .
PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 2012, 43 (06) :576-585
[6]   Validation of the Insomnia Severity Index as an outcome measure for insomnia research [J].
Bastien, Celyne H. ;
Vallieres, Annie ;
Morin, Charles M. .
SLEEP MEDICINE, 2001, 2 (04) :297-307
[7]  
Chen C. W., 2009, Archives of Clinical Psychology, V4, P59, DOI [10.6550/ACP.2009064(1).0005, DOI 10.6550/ACP.2009064(1).0005]
[8]   Assessment of fatigue using the Multidimensional Fatigue Inventory in patients with major depressive disorder [J].
Chung, Ka-Fai ;
Yu, Branda Yee-Man ;
Yung, Kam-Ping ;
Yeung, Wing-Fai ;
Ng, Tommy H. ;
Ho, Fiona Yan-Yee .
COMPREHENSIVE PSYCHIATRY, 2014, 55 (07) :1671-1678
[9]  
Committee for Medicinal Products for Human Use, 2015, GUID ADJ BAS COV CLI
[10]  
Daley M, 2009, SLEEP, V32, P55